Overcome Oncology Clinical Trial Obstacles – 2019 Real World Evidence for 2020 and Beyond
Overall the clinical trial market is growing at a robust pace that is expected to continue into 2024, owing to…
Going Above-and-Beyond – What Can Your Specialized Oncology CRO Do for You?
Clinical research is a growing and fascinating field marked by increasing complexity and competitive surroundings. CROs can help their Sponsors…
Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
Do Data Entry Issues & Backlog Threaten Your Clinical Trial?
6 Critical Factors for Prevention & Mitigation Collecting clinical data that are accurate, reliable and of high quality is the…
Daffodils & Cancer Research – what’s the connection?
The daffodil is a symbol of strength, of resilience, of courage and life. It survives our harsh Canadian winters to…
What to Look for When Selecting a CRO – Real World Evidence
There is a myriad of factors involved in selecting a CRO. Do CRO team members have the necessary therapeutic expertise?…
2018 in Retrospect – Real World Evidence of Win-Win CRO/Sponsor Relationships
What’s in Store for 2019 and Beyond? The Clinical Trials Market was valued at USD 32,700 million in 2017 and…
Real World Evidence of a Successful Oncology Trial Rescue in Canada
Each clinical study presents unique challenges, and it’s not unusual despite every effort that a clinical trial does not proceed…
‘5 step’ fail proof strategy to effective Clinical Trial Agreement Negotiations part 2
Continued from ‘5 step’ fail proof strategy to effective Clinical Trial Agreement Negotiation part 1 Nathan Currier, PhD, is Scimega's…
Busting Myths about the Canadian Regulatory Review Process – An interview with Susanne Picard
In this interview, Susanne Picard, Founder & President of SPharm Inc., answers questions about the Canadian regulatory environment and dispels…